Lpl Financial LLC Adamis Pharmaceuticals Corp Transaction History

Lpl Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$0.4 - $1.01 $4,730 - $11,943	-11,825 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.33 - $0.66 $990 - $1,980	-3,000 Reduced 20.24%	11,825 $6,000
Q1 2020 May 14, 2020	BUY	$0.33 - $0.89 $8 - $22	25 Added 0.17%	14,825 $5,000
Q4 2019 Feb 14, 2020	BUY	$0.51 - $1.26 $408 - $1,008	800 Added 5.71%	14,800 $10,000
Q1 2019 May 08, 2019	SELL	$2.02 - $3.22 $3,009 - $4,797	-1,490 Reduced 9.62%	14,000 $30,000

Q4 2018 Feb 07, 2019	SELL	$2.1 - $3.21 $14,910 - $22,791	-7,100 Reduced 31.43%	15,490 $35,000
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $2,250 - $4,800	1,000 Added 4.63%	22,590 $79,000
Q1 2018 May 15, 2018	BUY	$2.55 - $4.85 $24,990 - $47,530	9,800 Added 83.12%	21,590 $76,000
Q4 2017 Feb 14, 2018	SELL	$3.5 - $5.65 $4,025 - $6,497	-1,150 Reduced 8.89%	11,790 $52,000
Q3 2017 Nov 14, 2017	SELL	$4.5 - $5.65 $10,350 - $12,995	-2,300 Reduced 15.09%	12,940 $68,000
Q2 2017 Aug 14, 2017	BUY	N/A	15,240	15,240 $79,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.